Episode 78

#78: Our Take, October 28, 2019

Oct 28, 2019

8:43

Medical Devices Atrial Fibrillation Healthcare Business & Marketing

Episode Description

In this week’s Our Take, we’re covering the latest events in Biogen, involving their second life for aducanumab. To sign up for the weekly email brief, click here.

Other briefs include:

California releases its first report on drug pricing, in an effort to improve transparency.
Bristol-Myers Squibb-Pfizer Alliance is collaborating with Fitbit for atrial fibrillation detection.
Amazon is partnering with City of Hope to provide cancer support services to U.S. Amazon employees and their families.
Hackensack Meridian Health and Englewood Health have signed a definitive merger agreement.
RWJBarnabas Health has signed a non-binding letter of intent to acquire Trinitas Regional Medical Center and its affiliates.
Drug distributors McKesson, AmerisourceBergen, and Cardinal Health are discussing an agreement with state and local authorities to settle thousands of opioid-related lawsuits for $18 billion.

About Darwin Research Group

Darwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin’s client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

CONNECT WITH US:
🌐 Visit us on the web
🌐 Follow Health Care Rounds on LinkedIn
🌐 Follow Darwin Research Group on LinkedIn

📺 Watch Health Care Rounds on YouTube
🎧 Listen on Apple Podcasts
🎧 Listen on Spotify

⚙️ Health Care Rounds is produced by Grippi Media